Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haemochromatosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00395629
What this trial is testing

Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis

Who this might be right for
Iron OverloadHereditary Hemochromatosis
Novartis Pharmaceuticals 49
Not applicableLooking for participantsNCT07028112
What this trial is testing

Impact of Iron Overload on the Incidence of Liver Complications in Long-Term Survivors (≥10 Years) of Allogeneic Hematopoietic Stem-Cell Transplantation.

Who this might be right for
Iron OverloadHemosiderosisLiver Diseases+1 more
Assistance Publique - Hôpitaux de Paris 500
Post-approval studies (Phase 4)UnknownNCT05804071
What this trial is testing

Analysis of the Effect of Iron Supplements on Iron Deficiency Anemia in Pregnancy

Who this might be right for
Iron Deficiency Anemia of PregnancyIron Storage Disease
Qianfoshan Hospital 452
Testing effectiveness (Phase 2)Ended earlyNCT02263638
What this trial is testing

Treatment of Refractory Hemochromatosis Rheumatism by Anakinra: a Preliminary Phase II Study

Who this might be right for
Refractory Hemochromatosis Rheumatism
Rennes University Hospital 17
Not applicableLooking for participantsNCT05335603
What this trial is testing

An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis

Who this might be right for
Chronic Liver Disease
University of Copenhagen 335
Large-scale testing (Phase 3)Study completedNCT00171171
What this trial is testing

Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis

Who this might be right for
Beta-ThalassemiaHemosiderosis
Novartis 252
Large-scale testing (Phase 3)UnknownNCT01398644
What this trial is testing

Erythrocytapheresis Versus Phlebotomy as Maintenance Therapy in Hereditary Hemochromatosis (HH) Patients

Who this might be right for
Hereditary Hemochromatosis
Sanquin Research & Blood Bank Divisions 40
Post-approval studies (Phase 4)Study completedNCT00654589
What this trial is testing

Efficacy and Safety of Oral Deferasirox (20 mg/kg/d) in Pts 3 to 6 Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron Overload

Who this might be right for
Iron Overload
Novartis Pharmaceuticals 75
Not applicableStudy completedNCT00466063
What this trial is testing

ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox

Who this might be right for
Anemia
Novartis Pharmaceuticals 108
Not applicableStudy completedNCT01631708
What this trial is testing

Mi-iron - Moderately Increased Iron - is Reducing Iron Overload Necessary?

Who this might be right for
Hereditary Haemochromatosis
Murdoch Childrens Research Institute 100
Not applicableStudy completedNCT00199628
What this trial is testing

Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization

Who this might be right for
Glomerulonephritis, MembranousNeonatal Diseases and AbnormalitiesHemochromatosis
University Hospital, Limoges 100
Testing effectiveness (Phase 2)Study completedNCT04202965
What this trial is testing

PTG-300 in Subjects With Hereditary Hemochromatosis

Who this might be right for
Hereditary Hemochromatosis
Protagonist Therapeutics, Inc. 16
Not applicableStudy completedNCT03990181
What this trial is testing

Inhibiting Dietary Iron Absorption in Subjects With Hereditary Hemochromatosis by a Natural Polyphenol Supplement

Who this might be right for
Iron Metabolism DisordersIron OverloadPolyphenols
Swiss Federal Institute of Technology 14
Testing effectiveness (Phase 2)Study completedNCT00303329
What this trial is testing

Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients

Who this might be right for
AnemiaHemosiderosis
Novartis Pharmaceuticals 184
Post-approval studies (Phase 4)Study completedNCT00105495
What this trial is testing

Efficacy Study in Removing Excess Iron From the Heart

Who this might be right for
Thalassemia MajorHemosiderosis
ApoPharma 60
Testing effectiveness (Phase 2)Study completedNCT00349453
What this trial is testing

Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent Patients

Who this might be right for
Hemochromatosis
Lipomed 24
Large-scale testing (Phase 3)Study completedNCT00202436
What this trial is testing

Haemochromatosis:Phlebotomy Versus Erythrocytapheresis Therapy

Who this might be right for
Hemochromatosis
Sanquin Research & Blood Bank Divisions 40
Not applicableUnknownNCT01524757
What this trial is testing

Proton Pump Inhibitors in the Prevention of Iron Reaccumulation in Patient With Hereditary Hemochromatosis

Who this might be right for
Hemochromatosis
Maastricht University Medical Center 48
Large-scale testing (Phase 3)Study completedNCT00061750
What this trial is testing

Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions

Who this might be right for
Beta-Thalassemia
Novartis Pharmaceuticals 595
Not applicableLooking for participantsNCT03131427
What this trial is testing

China Registry for Genetic / Metabolic Liver Diseases

Who this might be right for
Genetic/Metabolic Liver Diseases
Beijing Friendship Hospital 20,000
Next Page